Toronto, Ontario, Canada
I build and scale AI and digital strategies that move beyond pilots to real-world products and enterprise outcomes. My work focuses on operationalizing and commercializing AI, ensuring bold ideas become trusted products and scalable operating models that improve lives. As an executive leader, former CEO, and builder, I’ve led transformations across life sciences, insurance, healthcare, and technology—from founding companies to unifying global teams. I thrive at the intersection of strategy and execution, where organizations must translate ambition into impact. What defines my work: – Turning AI ambition into measurable adoption and growth – Commercializing digital solutions in regulated industries – Designing scalable operating models that enable trust and long-term value – Leading with energy, humanity, and systems-level perspective I’ve led enterprise and product transformations where AI and digital strategy delivered measurable human and business outcomes. I redefined the strategy and operating model of a multinational digital health consultancy, steering it to sustainable growth and international expansion. I also commercialized an AI-driven cardiac monitoring product that improved patient engagement and achieved increased prevention and quality of life, while designing operating models in healthcare and insurance that embed digital for long-term adoption and trust. At the core, my passion is about improving the human condition through AI and digital transformation—from enabling healthier lives and more resilient healthcare, to creating insurance and enterprise systems that serve people better. My focus is on shaping how organizations operationalize AI at scale, building products and teams that deliver lasting value beyond the hype.
CurifyLabs advances precision medicine through 3D printing technology that enables personalized healthcare solutions. As Chairman, I worked with founders and VC investors to prepare the company for scaling and financing—shaping its go-to-market strategy, strengthening governance, and positioning it for sustainable international growth.
Brought in by investors to scale and internationalize a private equity-backed healthcare consulting, insights, and research company operating across the Nordic region and Europe. Accountable for company vision, strategy, profitability, and culture, while driving growth and positioning the business as a trusted partner to life sciences, healthcare providers, and government health authorities. Key achievements: • Scaled and internationalized operations, expanding the firm’s reach beyond the Nordics into key European markets. • Delivered profitability and sustainable growth, balancing short-term performance with long-term strategic direction. • Commercialized digital healthcare insights and consulting offerings, improving adoption and market competitiveness. • Partnered with pharmaceutical companies, hospitals, and public health authorities to embed new digital operating models and data-driven strategies, strengthening healthcare systems and outcomes. • Established a high-performance culture grounded in values, accountability, and collaboration.
Led enterprise-wide transformation for Roche’s 5,000-member global pharmaceutical development organization, shaping strategy, operating models, and digital adoption in one of the world’s most complex and regulated environments. Brought together technical depth and business leadership to ensure digital innovation translated into sustainable business and patient outcomes. Key achievements: • Redesigned operating models across R&D functions, improving agility and cross-functional collaboration. • Established FAIR data governance practices, enabling advanced analytics, AI, and machine learning at scale. • Advanced SaMD (Software as a Medical Device) readiness, aligning regulatory, data, and technology frameworks to support compliant digital product development. • Drove change management and communications to embed new digital ways of working across thousands of employees worldwide. • Partnered with senior leadership to connect investments to measurable patient and business impact.
Co-led 55-person cross-functional in-house management consulting group for global R&D pharma company. Created group strategy and operations, and led strategic advisory for senior leadership team of R&D.